title: Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review.
abstract: Neuroendocrine tumours (NET) are often diagnosed at an advanced stage when the prognosis is poor for patients, who often experience diminished quality of life (QoL). As new treatments for NET become available, it is important to characterise the associated outcomes, costs and QoL. A comprehensive search was performed to systematically review available data in advanced NET regarding cost of illness/resource utilisation, economic studies/health technology assessment and QoL. Four rounds of sequential review narrowed the search results to 22 relevant studies. Most focused on surgical procedures and diagnostic tools and contained limited information on the costs and consequences of medical therapies. Multiple tools are used to assess health-related QoL in NET, but few analyses have been conducted to assess the comparative impact of available treatment alternatives on QoL. Limitations include English language and the focus on advanced NET; ongoing terminology and classification changes prevented pooled statistical analyses. This systematic review suggests a lack of comparative economic and outcomes data associated with NET treatments. Further research on disease costs, resource utilisation and QoL for patients with advanced NET is warranted.
authors.affiliation: The Royal Marsden Hospital, London, UK.
authors.forename: I
authors.initials: I
authors.lastname: Chau
authors.forename: R
authors.initials: R
authors.lastname: Casciano
authors.forename: J
authors.initials: J
authors.lastname: Willet
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: J C
authors.initials: JC
authors.lastname: Yao
mesh_terms: D017048:Health Care Costs; D006296:Health Services / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D018358:Neuroendocrine Tumors / Q000191:economics / Q000473:pathology / Q000523:psychology; D011788:Quality of Life
keywords: health technology assessment; neuroendocrine; quality of life; resource utilisation
references.citation: Curr Oncol. 2006 Apr;13(2):67-76
references.pmid: 17576444
references.citation: J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
references.pmid: 8433390
references.citation: World J Gastroenterol. 2004 Dec 15;10(24):3628-33
references.pmid: 15534919
references.citation: Eur J Cancer Care (Engl). 2003 Mar;12(1):46-57
references.pmid: 12641556
references.citation: Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):163-72
references.pmid: 17382271
references.citation: Cancer. 2008 Nov 15;113(10):2655-64
references.pmid: 18853416
references.citation: Int J Technol Assess Health Care. 1998 Summer;14(3):514-25
references.pmid: 9780538
references.citation: Pancreas. 2010 Aug;39(6):707-12
references.pmid: 20664470
references.citation: N Engl J Med. 2011 Feb 10;364(6):501-13
references.pmid: 21306237
references.citation: Endocrinol Metab Clin North Am. 2011 Mar;40(1):97-109, viii
references.pmid: 21349413
references.citation: Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
references.pmid: 19622511
references.citation: Eur J Cancer. 2013 Dec;49(18):3780-7
references.pmid: 24012098
references.citation: J Clin Oncol. 2008 Jun 20;26(18):3063-72
references.pmid: 18565894
references.citation: Surgery. 2004 Dec;136(6):1218-26
references.pmid: 15657579
references.citation: Pancreas. 2010 Aug;39(6):753-66
references.pmid: 20664473
references.citation: Pancreas. 2009 Apr;38(3):e87-95
references.pmid: 19276865
references.citation: Am J Surg. 2007 May;193(5):610-3; discussion 613
references.pmid: 17434366
references.citation: Arch Surg. 2004 Mar;139(3):270-4
references.pmid: 15006883
references.citation: Acta Oncol. 2001;40(7):825-31
references.pmid: 11859981
references.citation: Neuroendocrinology. 2008;87(1):8-19
references.pmid: 18097129
references.citation: ANZ J Surg. 2006 Nov;76(11):987-95
references.pmid: 17054548
references.citation: N Engl J Med. 2011 Feb 10;364(6):514-23
references.pmid: 21306238
references.citation: JOP. 2009 May 18;10(3):276-9
references.pmid: 19454819
references.citation: Pancreatology. 2009;9(5):583-600
references.pmid: 19657214
references.citation: Pancreas. 2012 Apr;41(3):461-6
references.pmid: 22422138
references.citation: Cancer. 2008 Oct 1;113(7 Suppl):1807-43
references.pmid: 18798544
references.citation: Ann Oncol. 2008 Oct;19(10):1727-33
references.pmid: 18515795
references.citation: Ann Surg. 2009 Jan;249(1):63-71
references.pmid: 19106677
references.citation: Neuroendocrinology. 2009;89(3):296-301
references.pmid: 18840995
references.citation: Int J Colorectal Dis. 2007 Feb;22(2):183-9
references.pmid: 16845516
references.citation: Health Qual Life Outcomes. 2007 Apr 11;5:18
references.pmid: 17428340
references.citation: Arch Surg. 2003 Aug;138(8):859-66
references.pmid: 12912744
references.citation: J Clin Oncol. 2008 Jul 10;26(20):3403-10
references.pmid: 18612155
references.citation: J Clin Oncol. 2010 Jan 1;28(1):69-76
references.pmid: 19933912
references.citation: Dig Liver Dis. 2001 Apr;33(3):217-21
references.pmid: 11407665
references.citation: Qual Life Res. 2009 Aug;18(6):719-26
references.pmid: 19479341
references.citation: Pancreas. 2010 Aug;39(6):767-74
references.pmid: 20664474
references.citation: Endocr Rev. 2004 Jun;25(3):458-511
references.pmid: 15180952
references.citation: Best Pract Res Clin Endocrinol Metab. 2001 Jun;15(2):161-75
references.pmid: 11472032
references.citation: Lancet. 2011 Dec 10;378(9808):2005-2012
references.pmid: 22119496
references.citation: Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:19-26
references.pmid: 21308478
references.citation: Ann Oncol. 2010 May;21 Suppl 5:v223-7
references.pmid: 20555086
references.citation: Am J Clin Oncol. 2010 Feb;33(1):83-8
references.pmid: 19704366
references.citation: J Clin Oncol. 2004 Jul 1;22(13):2724-9
references.pmid: 15226340
references.citation: Clin Transl Oncol. 2009 Jan;11(1):48-53
references.pmid: 19155204
references.citation: Dig Surg. 2007;24(6):463-70
references.pmid: 18057893
references.citation: J Clin Oncol. 2011 Mar 1;29(7):934-43
references.pmid: 21263089
references.citation: Surgery. 2004 Dec;136(6):1176-82
references.pmid: 15657573
references.citation: Curr Opin Oncol. 2007 Jan;19(1):30-5
references.pmid: 17133109
references.citation: World J Gastroenterol. 2009 Oct 28;15(40):5067-73
references.pmid: 19860000
references.citation: Eur J Cancer Care (Engl). 2007 Nov;16(6):493-9
references.pmid: 17944763
references.citation: Scand J Caring Sci. 2009 Mar;23(1):107-16
references.pmid: 19250453
references.citation: Endocr Relat Cancer. 2003 Dec;10(4):483-6
references.pmid: 14713261
references.citation: Surgery. 2007 Jul;142(1):10-9
references.pmid: 17629995
references.citation: Eur J Cancer. 2006 Mar;42(4):477-84
references.pmid: 16412628
references.citation: Cancer. 2000 Feb 15;88(4):770-6
references.pmid: 10679645
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4656-63
references.pmid: 19704057
references.citation: J Clin Oncol. 2006 Jan 1;24(1):25-35
references.pmid: 16314617